Sitafloxacin Activity Against Helicobacter Pylori Isolates, Including Those With gyrA Mutations

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01552-08
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Diversity Among Helicobacter Pylori Isolates.

Journal of Clinical Microbiology
Microbiology
1996English

Direct Activity of Recombinant Human Lactoferrin Against Helicobacter Pylori.

Journal of Clinical Microbiology
Microbiology
1996English

In Vitro Antibacterial Activity of PHX-3 Against Helicobacter Pylori

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2010English

Antimicrobial Activity of Natural Products Against Helicobacter Pylori: A Review

Annals of Clinical Microbiology and Antimicrobials
MedicineInfectious DiseasesMicrobiology
2014English

Mechanism of Antibacterial Activity of Liposomal Linolenic Acid Against Helicobacter Pylori

PLoS ONE
Multidisciplinary
2015English

Single and Double Mutations in gyrA but Not in gyrB Are Associated With Low- And High-Level Fluoroquinolone Resistance in Helicobacter Pylori

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2003English

Antibacterial Activity of Ethoxzolamide Against Helicobacter Pylori Strains SS1 and 26695

Gut Pathogens
VirologyParasitologyInfectious DiseasesMicrobiologyGastroenterology
2020English

Antimicrobial Activity of the Essential Oil of Thymus Capitatus Against Helicobacter Pylori

Acta Poloniae Pharmaceutica
PharmacologyPharmaceutical Science
2020English

In-Vitro Characterisation of a Novel Antimicrobial Agent, TNP-2092, Against Helicobacter Pylori Clinical Isolates

Swiss Medical Weekly
Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy